首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Neoplasia

Neoplasia杂志,由Neoplasia Press出版,于1999年创刊,Monthly,出版语言English,ISSN:1476-5586,E-ISSN:1476-5586。

投稿咨询
Neoplasia
Neoplasia
Neoplasia
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
2区
影响因子
4.8
CiteScore
11.4
期刊收录
SCI、SCIE

Neoplasia(中文译名:《瘤形成》),ISSN:1476-5586,EISSN:1476-5586,是Neoplasia Press出版的国际性学术期刊,创刊于1999年,以Monthly形式稳定发行,2026年总发文量约127篇。该刊采用OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.8,2025年期刊CiteScore为11.4,2025年期刊自引率约2.1%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Neoplasia长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期12 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、GERMANY (FED REP GER)、Japan、Canada、Taiwan、England等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMUNIVERSITY OF MICHIGAN SYSTEM、HELMHOLTZ ASSOCIATION、SHANGHAI JIAO TONG UNIVERSITY、HARVARD UNIVERSITY、NANJING MEDICAL UNIVERSITY、UNIVERSITY OF CALIFORNIA SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 92 / 333

72.5

学科:ONCOLOGY SCIE Q1 47 / 333

86.04

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 48 / 322

85.2

学科:ONCOLOGY SCIE Q1 45 / 322

86.18


中国学者近期发文

1
Assessing axitinib-induced differential responses in tumor vascularization and oxygenation with combined optoacoustic angiography and diffuse optical spectroscop

Author:Orlova, Anna; Akhmedzhanova, Ksenia; Glyavina, Anna; Kurnikov, Alexey; Khochenkov, Dmitry; Khochenkova, Yulia; Korobov, Artemii; Volovetskiy, Artur; Yudintsev, Andrey; Nerush, Anastasiya; Maslennikova, Anna; Vodeneev, Vladimir; Turchin, Ilya; Liu, Wei; Razansky, Daniel; Subochev, Pavel

Journal: NEOPLASIA. 2026; Vol. 76, Issue , pp. -. DOI: 10.1016/j.neo.2026.101303

2
BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppressio

Author:Wu, Meng-Zhi; Feng, Dou; Liu, Wu-Ping; Huang, Wei-Lun; Wu, Qiang; Chou, Tian-Sheng; Xiao, Wen-Hao; Yao, Zhou-Zhou; Li, Zhen-Jiang; Xie, Ting-Ting; Chen, Chang-Han; Yang, Zhi-Yu; Mao, Rui-Wen; Wu, Ci-Chun; Wang, Jun-Cheng; Zhang, Yu-Jin; Kellems, Rodney E.; Xia, Yang

Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101299

3
PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP7

Author:Teng, Hongming; Guo, Yuxin; Chen, Xinran; Fan, Anlian; Zhang, Chengfei; Zhang, Ting; Luo, Yuanyuan; Huang, Lin

Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101297

4
The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RC

Author:Kuroda, Shoichiro; Funasaki, Shintaro; Nishizawa, Hidekazu; Schmidt, Laura S.; Kurahashi, Ryoma; Ito, Takaaki; Arima, Yuichiro; Tanaka, Miwa; Kitada, Atsuya; James, Amy M.; Hasumi, Hisashi; Jikuya, Ryosuke; Makiyama, Kazuhide; Kurotaki, Daisuke; Minami, Takashi; Difilippantonio, Simone; Linehan, W. Marston; Oike, Yuichi; Sawa, Tomohiro; Tanaka, Yasuhito; Suda, Toshio; Yokokawa, Ryuji; Nakamura, Takuro; Baba, Masaya; Kamba, Tomomi

Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101296

5
ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesi

Author:Chen, Xun; Wan, Jian; Jiang, Zhengwu; Zhao, Zhijian; Tang, Caixi; Li, Yukun; Wang, Dong

Journal: NEOPLASIA. 2026; Vol. 75, Issue , pp. -. DOI: 10.1016/j.neo.2026.101298

6
Mechanistic insights and therapeutic interventions of mitochondrial quality control in chemotherapy-related cognitive impairmen

Author:Chen, Jie; Chu, Xinyu; Wu, Yue; Su, Li; Wang, Mingqi; Zhao, Xuemei; Wei, Xiaohong; Xia, Guiyang; Xia, Huan; Lin, Sheng; Zhang, Mei

Journal: NEOPLASIA. 2026; Vol. 74, Issue , pp. -. DOI: 10.1016/j.neo.2026.101291

7
Microbial crosstalk along the oral-gut axis: organ-specific oncogenic adaptations of Porphyromonas gingivalis and Fusobacterium nucleatu

Author:Wu, Shiwang; Ye, Xinyi; Wang, Jingsi; Li, Mei; Fu, Yage; Wang, Shan

Journal: NEOPLASIA. 2026; Vol. 74, Issue , pp. -. DOI: 10.1016/j.neo.2026.101290

8
MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosi

Author:Wang, Bishi; Wu, Kongxiu; Liu, Xin; Shen, Yuhai; Li, Yanliang

Journal: NEOPLASIA. 2026; Vol. 73, Issue , pp. -. DOI: 10.1016/j.neo.2025.101270

9
The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cance

Author:Sun, Keran; Ning, Jingyuan; Jia, Keqi; Fan, Xiaoqing; Li, Hongru; Ma, Cuiqing; Wei, Lin

Journal: NEOPLASIA. 2026; Vol. 73, Issue , pp. -. DOI: 10.1016/j.neo.2026.101277

10
Experimental study of tumor-associated macrophage-derived SPP1 inhibit CD8+T cells to promote Colorectal cancer progressio

Author:Hao, Cheng-Fei; Sun, Zhao-Nan; Chen, Guo-Shan; Zhang, Bao-Tong; Xiong, Wen-Hao; Zhang, Xi-Bo; Qi, Feng

Journal: NEOPLASIA. 2026; Vol. 73, Issue , pp. -. DOI: 10.1016/j.neo.2026.101276


在线咨询

Neoplasia

国际简称:NEOPLASIA参考译名:瘤形成

年发文量:127 CiteScore:11.4 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:94.49%

杂志社联系方式:STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169

Neoplasia